Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Myostatin(GDF-8), Human, recombinant for Sale > FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - large image1
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image1
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image2
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image3
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image4
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image5
FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder buy - image6

FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder

TDS 2 Inquiries

Unit Price:

$50/UNIT FOB

Get Latest Price
CAS No.:

271597-12-7

Grade:

Research Grade

Content:

99%

Port:

深圳

Brand:

Generic

Packaging:

10mg/Vial

Price valid (until):

2026-10-09

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Peptides

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Name:Elare

    Whatsapp:+852 5535 7215

    Please add me for our latest price list and COA


      Product Detail  





    FOXO4 10mg – Product Description

    Product Overview

    FOXO4 10mg is presented as a specified-strength product for professional and qualified commercial customers. This product description is intended to provide factual, neutral, and transparent information for product identification and preliminary commercial evaluation.

    The exact identity, composition, specifications, quality characteristics, packaging, storage conditions, transportation requirements, and regulatory status of the product should be confirmed against the manufacturer's current official documentation before purchase or commercial use.

    This listing does not constitute a medical claim, therapeutic recommendation, regulatory certification, or confirmation that the product is exempt from any applicable laws, regulations, licensing requirements, or marketplace qualification procedures.

    Basic Product Information

    • Product Name: FOXO4 10mg
    • Strength: 10 mg
    • Product Category: To be confirmed according to official manufacturer documentation
    • Product Form: To be confirmed
    • Principal Component: To be confirmed
    • Chemical/Technical Name: To be confirmed where applicable
    • CAS Number: To be confirmed where applicable
    • Molecular Formula: To be confirmed where applicable
    • Molecular Weight: To be confirmed where applicable
    • Appearance: To be confirmed
    • Assay/Purity: To be confirmed
    • Packaging: To be confirmed
    • Manufacturer: To be confirmed
    • Country/Region of Origin: To be confirmed
    • Batch Information: Subject to applicable supplier documentation

    Only information supported by official specifications, certificates, quality records, or other appropriate documentation should be entered into the final product listing.

    Product Characteristics

    FOXO4 10mg is supplied according to the confirmed manufacturer specification. Product characteristics may vary depending on the manufacturer, formulation, production process, packaging configuration, and production batch.

    Customers requiring particular technical specifications should communicate their requirements to the supplier before placing an order. Any agreed specifications should be confirmed through appropriate technical documentation before commercial acceptance.

    Information regarding composition, purity, assay, manufacturing standards, certification, registration, or regulatory status should not be inferred solely from the product name or stated strength.

    Where batch-specific documentation is available, customers should review the applicable documentation to confirm that the supplied product corresponds to the required specifications.

    Quality and Technical Documentation

    Quality information should be evaluated using current documentation issued or provided by the manufacturer or authorized supplier.

    Depending on the actual product and transaction, applicable documentation may include:

    • Product specification sheet
    • Certificate of Analysis (COA)
    • Safety Data Sheet (SDS), where applicable
    • Batch-related quality documentation
    • Packaging and labeling information
    • Product traceability documentation
    • Other documents required by the destination market or transaction

    Customers with specific quality requirements should request and review the appropriate documentation before completing a purchase.

    No unsupported claim concerning purity, certification, registration, manufacturing standards, testing, or quality assurance should be added to the listing.

    Packaging

    FOXO4 10mg should be supplied in packaging consistent with the confirmed manufacturer specification.

    Actual packaging configuration, container type, unit quantity, labeling, batch identification, shelf-life or retest information, and other packaging details should be verified before shipment.

    The final packaging and labeling should comply with applicable requirements for the actual product, destination market, and transportation method.

    Customers should not rely exclusively on an online listing to determine whether a particular packaging configuration satisfies import, storage, transportation, or distribution requirements.

    Storage Conditions

    Storage requirements should be based on the manufacturer's current official documentation.

    The product should be maintained in its original, appropriately identified packaging and protected from environmental conditions that may adversely affect product quality.

    Specific requirements relating to temperature, humidity, light exposure, shelf life, handling conditions, or other storage parameters should only be stated when supported by official product documentation.

    Professional customers should review the applicable technical and safety documents before receiving, storing, or handling the product.

    Regulatory and Compliance Information

    The regulatory status of a product depends on its exact identity, composition, formulation, concentration, packaging, intended transaction, and jurisdiction.

    Customers and suppliers are responsible for determining the requirements applicable to the actual product in the country or region where it will be imported, exported, stored, transported, distributed, or otherwise handled.

    If the product or any component is subject to hazardous chemical controls, controlled-substance requirements, pharmaceutical regulations, import or export restrictions, registration requirements, licensing requirements, or other regulatory controls, all applicable qualifications, permits, registrations, declarations, labeling, packaging, transportation procedures, and supporting documentation must be obtained and maintained as required by law.

    This listing does not state or imply that FOXO4 10mg is exempt from any regulatory framework.

    It also does not provide instructions for avoiding regulatory review, bypassing marketplace verification, concealing product classification, or circumventing qualification requirements.

    Where ECHEMI or another marketplace requests qualification documents, permits, certificates, registrations, or other supporting documentation, the supplier and customer should follow the platform's designated verification process.

    Intended Commercial Use

    FOXO4 10mg should only be purchased, handled, stored, transported, distributed, or otherwise used in accordance with applicable laws, regulations, and the manufacturer's official documentation.

    This listing is intended for product identification and commercial communication. It does not provide instructions for unauthorized synthesis, formulation, modification, processing, administration, or other activities that may be restricted or regulated.

    No therapeutic, diagnostic, preventive, anti-aging, disease-treatment, performance-enhancement, or other medical efficacy claim is made in this product description.

    Any application requiring professional authorization, regulatory approval, prescription status, professional supervision, or other legal conditions must be conducted only by appropriately qualified parties and in accordance with applicable requirements.

    Safety Information

    Customers should review the applicable Safety Data Sheet and other official safety documentation before handling the product where such documentation is available or required.

    Safety precautions should be determined according to the confirmed classification and characteristics of the actual product.

    Where applicable, customers should follow the manufacturer's instructions and relevant requirements concerning personal protection, storage, handling, transportation, spill response, waste management, and emergency procedures.

    This listing does not characterize the product as “completely safe,” “risk-free,” “non-toxic,” “non-hazardous,” or exempt from regulation unless such a statement is specifically supported by authoritative documentation and is legally permissible.

    If this general listing differs from the manufacturer's current technical or safety documentation, the applicable official documentation should be treated as the controlling reference.

    Transportation and Shipment

    Transportation requirements may depend on the confirmed product classification, packaging, quantity, destination, and transportation method.

    Before shipment, the supplier and customer should determine whether additional labeling, packaging, declarations, permits, certificates, or carrier requirements apply.

    Accurate consignee and destination information should be provided so that applicable transportation and compliance requirements can be assessed.

    This product description does not guarantee customs clearance,

    Items Specifications
    Product Name FOXO4
    Grade Research Grade
    Package 10mg/Vial
    Appearance White Lyophilized Powder
    Model FOXO4 10mg
    Brand Generic

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 1

    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 2
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 3
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 4
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 5
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 6
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 7
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 8
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 9
    Shop Retatrutide 15mg High Purity Peptide Research Compound Powder Product-Detailed Image 10
    ECHEMI Editorial Reference
    Myostatin is a kind of TGF-β family discovered as a factor involved in the modulation of the number of muscles. It inhibits the growth of skeletal muscles, and in knockout mice, an increase in skeletal muscles and a decrease in body fat mass have been reported. Myostatin activity is inhibited by follistatin, an activin-binding protein and myostatin propeptide. Growth Differentiation Factor 8 (GDF-8), also known as myostatin, is a member of the TGF-beta superfamily expressed specifically in developing and adult skeletal muscle. GDF-8 cDNA encodes a 376 amino acid (aa) prepropeptide with a 24 aa residue signal peptide, a 223 aa residue amino-terminal propeptide, and a 109 aa residue carboxy-terminal mature protein. Mature GDF-8 contains the canonical 7-cysteine motif common to other TGF-beta superfamily members.
    Research & Reference Note

    FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates
    • FOXO4 10mg Peptide Research Product, 10mg Vial, Lyophilized Powder Certificates 1 TDS

    Basic Info
    Product Name:

    Myostatin(GDF-8), Human, recombinant

    Other Name:

    Myostatin(GDF-8), Human, recombinant;Myostatin (GDF-8) 1mg

    CAS No.:

    271597-12-7

    Molecular Weight:

    0

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Y17, Room 310, East Third Floor, No. 64 and 66 Jianzhong Road, Tianhe District, Guangzhou City

    Payment Terms:

    TT against copy of documents,100% TT in advance

    Average lead Time:

    1

    Total Employees:

    11-50

    Year of Establishment:

    2026

    Founded in 2024, PGpeptides is a specialized supplier of high-purity
    research peptides serving the global scientific community. With deep
    industry expertise, we deliver consistent product quality, competitive
    pricing, and flexible service tailored to research institutions, laboratories,
    and distributors worldwide.
    Our operations span North America, Europe, Asia, Australia, and the
    Middle East, backed by a mature international trade infrastructure and a
    reliable global fulfillment network. We have earned strong recognition 
    and trust across the markets we serve.
  • Inquiry History
    2 Inquiries
    Country Product Purchase Quantity Date Posted
    Lithuania

    gdf8

    10 G Feb 28, 2026
    United States

    Gdf-8

    10 MG Feb 22, 2025
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.